Institutional investors purchased a net $9.0 million shares of TXMD during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 62.01% of outstanding shares held by institutions is the lowest percentage in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OLD MUTUAL INVESTMENT MANAGEMENT... Bought 61.8 Thousand shares of TherapeuticsMD Inc
INSIDERFONDER AB Sold 5.6 Thousand shares of TherapeuticsMD Inc
BB&T SECURITIES LLC Sold 17.0 Thousand shares of TherapeuticsMD Inc